Navigation Links
PRC Clinical Partners With SDC to Expand ClinPulse Event Series to the Boston Biotech Hub
Date:9/13/2017

PRC Clinical and SDC are organizing a ClinPulse panel and networking event on Thursday, September 21st from 6 to 8:30pm EDT at Catalyst in Cambridge, MA.

Clinical operations experts will discuss the topic of “Proactive Patient Enrollment Strategies for Clinical Operations Professionals.” From tracking enrollment progress to communicating with underperforming sites to engaging with patient advocacy networks, expert panelists will share best practices and insights on proactive patient enrollment strategies.

The ClinPulse Boston panel will be comprised of:

  • Melissa Price, Vice President, Clinical Development, TARIS Biomedical
  • Roger D. Nolan, Ph.D., Co-Founder, President and COO, Biokier
  • Carole Ann McEvoy, Clinical Study Manager, PRC Clinical
  • Faith Kolb, Vice President, Biometric Operations, SDC
  • Bryce Warren, Ph.D., Executive Consultant in Clinical Operations

“We are thrilled to have such a wonderful lineup of speakers for our first ClinPulse event in Boston” said Tony Taricco, President & COO at PRC Clinical. “Our panelists come from diverse backgrounds within Clinical Operations and Clinical Trial Management. Their unique perspectives will make for an engaging and educational discussion.”

Registration is open at prcclinical.com/boston. Local Clinical Operations professionals are invited to join this free event to learn how to better approach:

  • Drift & Wobble – Tracking enrollment progress and hitting goals
  • The Zen of Enrollment – Training tips and mantras for sustained focus
  • Phone Fatigue – Communicating with sites and sharing key performance data
  • Are we a Match? – Selecting the right CROs to help you reach your goals
  • Safety Net(works) – Leveraging patient networks and advocacy groups

The Boston region hosts a large biotech community with over 50,000 employees in bioscience-related jobs. The expansion of the ClinPulse event series gives PRC Clinical the ability to leverage its repeated presence at local conferences and better serve pharmaceutical, biotech and regenerative medicine developers in the Boston area.

About ClinPulse

The ClinPulse Expert Event Series focuses on the drivers of change in clinical trials. PRC Clinical and its partners have organized four sessions in the San Francisco Bay Area and one session in San Diego, CA. They aim at gathering subject matter experts to discuss long-term trends and look at ways people are exploring and acting on these themes. Previous events included speakers from the FDA, Genentech, Celgene, Nektar, the California Institute for Regenerative Medicine (CIRM), and BioMarin Pharmaceuticals. Learn more at prcclinical.com/clinpulse

About PRC Clinical

PRC Clinical is the CRO of choice for many pharmaceutical, biotech and regenerative medicine developers worldwide, offering a next-level clinical trial management experience. Our innovative approach to executing studies merges our high-touch human element with high-tech tools, extensive experience and deep knowledge – far exceeding the level of service offered by large CROs. We offer full Clinical Trial Management services including Clinical Project Management, Site Monitoring, Site Selection, and Site Management. PRC Clinical has significant experience in a wide range of therapeutic areas: Regenerative Medicine, CNS, Neurology, ALS, Parkinson’s, Pain, GI, Device, Anti-infective, Cardiovascular, Pulmonary, Oncology, and Stem Cells. Visit http://www.prcclinical.com, call 1-877-519-6001, or email info(at)prcclinical.com.

About SDC

SDC is committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. SDC delivers leading-edge statistical analysis and data management services to pharmaceutical, biotechnology, and medical device companies, as well as CRO partners. With biostatistics, clinical data management/EDC, and interactive response technology (IRT) expertise at our core, SDC also provides scalable full service clinical trial solutions via our diverse and complementary strategic partnerships. Speak with us today about how SDC will take ownership of your clinical project needs. For more information, please visit http://www.sdcclinical.com, call 480-632-5468, or email data(at)sdcclinical.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14687870.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
3. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
4. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
5. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
6. Clinical Trials and Medical Research in Texas Create Jobs and Save Lives
7. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
8. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
9. Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
10. ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical Trials
11. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2019)... ... 08, 2019 , ... VGI Medical was founded in 2007 based on an ... to the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems ... patented dual geometric design to limit motion of the affected spinal segment. Applying the ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today announced ... candidate, code-named "KM-819." KM-819 is an orally active small molecule that is ... Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to ...
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life , ... in blood, has been named as a partner in Medigen Biotech’s upcoming cell ... therapies for cancer treatment, will use CellMax Life’s circulating tumor cell platform CMxTM, ...
(Date:12/19/2018)... ... December 19, 2018 , ... R3 Stem ... Stem Cell Training Course in Las Vegas. Training includes facial rejuvenation, hair restoration ... in popularity nationwide for aesthetics, having the training from expert, Board Certified providers ...
Breaking Biology Technology:
(Date:12/19/2018)... ... December 19, 2018 , ... InTouchMD’s flagship product, Pulse ... healthcare for 2018. , PM360 is featuring the recognition in its 7th annual ... services offered to the pharmaceutical and medical device industries. , “This recognition comes at ...
(Date:12/14/2018)... ... December 14, 2018 , ... ... 9,703,929 entitled “Method and System for Microbiome-Derived Diagnostics and Therapeutics” by the US ... October 21, 2014. The patent is an invention by uBiome collaborators Dr. Zachary ...
(Date:12/13/2018)... LAKELAND, Fla. (PRWEB) , ... December 12, 2018 , ... ... and preventing the growing problem of drowsy and distracted driving, one of the main ... project, under the guidance of Dr. Kanwal Gagneja , assistant professor of computer ...
Breaking Biology News(10 mins):